These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36034832)

  • 1. Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report.
    Zhao J; Dai K; Xie J; Fang C; Chen N; Dai J; Xu D
    Front Pharmacol; 2022; 13():927299. PubMed ID: 36034832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
    Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
    Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature.
    Gong P; Zhuang Q; Wang K; Xu R; Chen Y; Wang X; Yin S
    Medicine (Baltimore); 2018 Jun; 97(24):e11023. PubMed ID: 29901594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with
    Hu L; Li L; Li A; Tong J
    Open Med (Wars); 2024; 19(1):20240985. PubMed ID: 38953008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma.
    Liu N; Chen Y; Yang L; Shi Q; Lu Y; Ma W; Han X; Guo H; Li D; Gan W
    Clin Transl Med; 2022 Apr; 12(4):e797. PubMed ID: 35452181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
    Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
    BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xp11.2 Translocation Renal Cell Carcinoma With
    Ge Y; Lin X; Zhang Q; Lin D; Luo L; Wang H; Li Z
    Front Oncol; 2021; 11():784993. PubMed ID: 34917511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report.
    Yang K; Ma Y; Dai S; Dong R
    Front Pediatr; 2023; 11():1141223. PubMed ID: 37528880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review.
    Masago T; Kobayakawa S; Ohtani Y; Taniguchi K; Naka T; Kuroda N; Takahashi C; Isoyama T; Sejima T
    Int Cancer Conf J; 2020 Oct; 9(4):182-186. PubMed ID: 32903928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.
    Pan X; Quan J; Zhao L; Li W; Wei B; Yang S; Lai Y
    Mol Clin Oncol; 2018 Jan; 8(1):83-85. PubMed ID: 29399348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma.
    Guo W; Zhu Y; Pu X; Guo H; Gan W
    Front Oncol; 2023; 13():1116648. PubMed ID: 36816933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
    Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
    Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.
    Kim SH; Choi Y; Jeong HY; Lee K; Chae JY; Moon KC
    Virchows Arch; 2011 Sep; 459(3):299-306. PubMed ID: 21773754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions-single-center study].
    Ma WL; Liu N; Zhuang WY; Li XG; Zhang GT; Gan WD; Guo HQ
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(38):3068-3073. PubMed ID: 30392265
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.
    Kurisaki-Arakawa A; Saito T; Takahashi M; Mitani K; Fukumura Y; Nagashima Y; Argani P; Yao T
    Int J Clin Exp Pathol; 2013; 6(11):2585-90. PubMed ID: 24228124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review.
    Yang D; Tang W; Liu M; Xie Z; Shi F; Zhao Z; Yang X; Wu T
    Oncol Lett; 2024 Jan; 27(1):29. PubMed ID: 38073770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnant patient with Xp11.2/transcription factor E3 translocation renal cell carcinoma: a case report and literature review.
    Wang Y; Guo X; Meng Z; Cui Y; Sun Y
    Front Oncol; 2024; 14():1388880. PubMed ID: 38988705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis.
    Al-Maghrabi J; Mufti S; Gomaa W
    Pol J Pathol; 2018; 69(4):376-383. PubMed ID: 30786687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.